|
SCS/SB 28 - This act provides that the anti-kickback penalties specified in Section 191.905 will not apply to certain programs established by pharmaceutical companies. These programs provide partial rebates of private health insurance copayments to patients with multiple sclerosis or other chronic, potentially disabling or life-threatening conditions who have been prescribed disease-managing medicines for which there are no generic equivalents. ADRIANE CROUSE
|
